Determination of Protein Extinction Coefficients and Concentration by UV‑Vis

Significance of the topic

Accurate determination of protein extinction coefficients and concentrations is fundamental in analytical chemistry and biopharmaceutical development. These measurements underpin studies of protein–protein and protein–ligand interactions, enzyme activity assays, and quality control of therapeutic proteins such as monoclonal antibodies and vaccines. High-throughput, reliable quantification supports efficient drug discovery, manufacturing, and regulatory compliance.

Objectives and study overview

The study demonstrates the performance of the Agilent Cary 3500 Multicell UV-Vis spectrophotometer combined with Agilent Cary Workstation software for automated determination of protein extinction coefficients and concentrations. Key aims include streamlining measurements via custom equation functions, validating results against sequence-based calculations, and comparing extinction coefficients of an innovator monoclonal antibody (Ristova) with two biosimilars (Reditux, Truxima).

Methodology and instrumentation

Samples of lysozyme, β-casein, ovalbumin, Ristova, Reditux, and Truxima were prepared at defined concentrations in 6 M guanidine hydrochloride. Measurements were performed on the Agilent Cary 3500 Multicell UV-Vis using scan range 240–325 nm, spectral bandwidth 2 nm, scan rate 3000 nm/min, and 10 mm pathlength microvolume cells (50 µL). The Cary Workstation software’s built-in equation editor applied the Beer–Lambert law (A=ε·c·L) and sequence-derived extinction coefficient calculations to automate data processing and correct for baseline scattering at 320 nm.

Main results and discussion

The software simultaneously measured seven sample channels and one reference, yielding extinction coefficients for all test proteins that closely matched literature values and sequence-based predictions. At both 1 and 0.5 mg/mL, the biosimilars Reditux and Truxima exhibited absorption-derived coefficients indistinguishable from the innovator Ristova, confirming similar aromatic amino acid content. A calibration curve for Ristova (0.1–2 mg/mL) showed excellent linearity (R²=0.9918), demonstrating suitability for concentration estimation during bioprocessing.

Benefits and practical applications

• High-throughput measurement of multiple samples in a single run
• Automated extinction coefficient and concentration calculations minimize manual intervention
• Reliable comparison of innovator and biosimilar products for regulatory and QC purposes
• Rapid, reproducible results support process monitoring in mAb production

Future trends and applications

Continued integration of UV-Vis systems with laboratory information management systems (LIMS) and robotic sample handling will enhance throughput. Expansion of software capabilities to include real-time monitoring and coupling with orthogonal techniques (e.g., circular dichroism, mass spectrometry) can further improve protein characterization. Advanced analytics and machine learning may refine predictive models for extinction coefficients based on sequence variations.

Conclusion

The Agilent Cary 3500 Multicell UV-Vis spectrophotometer, paired with Cary Workstation software, delivers rapid, accurate, and automated determination of protein extinction coefficients and concentrations. This solution enhances laboratory efficiency, ensures data reproducibility, and supports critical decision-making throughout biopharmaceutical development and quality control.

Reference

• Rathore AS. Follow-On Protein Products: Scientific Issues, Developments and Challenges. Trends Biotechnol. 2009;27(12):698–705.
• Nupur N, Chhabra N, Dash R, Rathore AS. Assessment of Structural and Functional Similarity of Biosimilar Products: Rituximab as a Case Study. MAbs. 2018;10(1):143–158.
• Gill SC, Von Hippel PH. Calculation of Protein Extinction Coefficients from Amino Acid Sequence Data. Anal Biochem. 1989;182(2):319–326.
• NovoPro Bioscience Inc. Protein Extinction Coefficients and Concentration Calculation. Accessed April 22, 2025.
• Petrat-Melin B, Andersen P, Rasmussen JT, et al. In Vitro Digestion of Purified Β-Casein Variants. J Dairy Sci. 2015;98(1):15–26.
• Lee KH, Lee J, Bae JS, et al. Analytical Similarity Assessment of Rituximab Biosimilar CT-P10 to Reference Medicinal Product. MAbs. 2018;10(3):380–396.